<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-11-08" modified="2017-05-10" version="151">
<accession>O95786</accession>
<accession>A2RU81</accession>
<accession>Q5HYE1</accession>
<accession>Q5VYT1</accession>
<accession>Q9NT04</accession>
<name>DDX58_HUMAN</name>
<protein>
<recommendedName>
<fullName>Probable ATP-dependent RNA helicase DDX58</fullName>
<ecNumber>3.6.4.13</ecNumber>
</recommendedName>
<alternativeName>
<fullName>DEAD box protein 58</fullName>
</alternativeName>
<alternativeName>
<fullName>RIG-I-like receptor 1</fullName>
<shortName>RLR-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Retinoic acid-inducible gene 1 protein</fullName>
<shortName>RIG-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Retinoic acid-inducible gene I protein</fullName>
<shortName>RIG-I</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">DDX58</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="thesis" date="1997" institute="Shanghai Institute of Hematology" country="China">
<title>RIG-I, a human homolog gene of RNA helicase, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell.</title>
<authorList>
<person name="Sun Y.-W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT GLU-580</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="292" first="274" last="279">
<title>Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2.</title>
<authorList>
<person name="Imaizumi T."/>
<person name="Aratani S."/>
<person name="Nakajima T."/>
<person name="Carlson M."/>
<person name="Matsumiya T."/>
<person name="Tanji K."/>
<person name="Ookawa K."/>
<person name="Yoshida H."/>
<person name="Tsuchida S."/>
<person name="McIntyre T.M."/>
<person name="Prescott S.M."/>
<person name="Zimmerman G.A."/>
<person name="Satoh K."/>
</authorList>
<dbReference type="PubMed" id="11890704"/>
<dbReference type="DOI" id="10.1006/bbrc.2002.6650"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT GLU-580</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-748 (ISOFORM 2)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 528-925 (ISOFORMS 1/2)</scope>
<scope>VARIANT CYS-7</scope>
<source>
<tissue>Skin</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Biochem. Cell Biol." volume="82" first="401" last="405">
<title>Retinoic acid-inducible gene-I is induced by interferon-gamma and regulates the expression of interferon-gamma stimulated gene 15 in MCF-7 cells.</title>
<authorList>
<person name="Cui X.-F."/>
<person name="Imaizumi T."/>
<person name="Yoshida H."/>
<person name="Borden E.C."/>
<person name="Satoh K."/>
</authorList>
<dbReference type="PubMed" id="15181474"/>
<dbReference type="DOI" id="10.1139/o04-041"/>
</citation>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Life Sci." volume="75" first="1171" last="1180">
<title>Expression of retinoic acid-inducible gene-I in vascular smooth muscle cells stimulated with interferon-gamma.</title>
<authorList>
<person name="Imaizumi T."/>
<person name="Yagihashi N."/>
<person name="Hatakeyama M."/>
<person name="Yamashita K."/>
<person name="Ishikawa A."/>
<person name="Taima K."/>
<person name="Yoshida H."/>
<person name="Inoue I."/>
<person name="Fujita T."/>
<person name="Yagihashi S."/>
<person name="Satoh K."/>
</authorList>
<dbReference type="PubMed" id="15219805"/>
<dbReference type="DOI" id="10.1016/j.lfs.2004.01.030"/>
</citation>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Nat. Immunol." volume="5" first="730" last="737">
<title>The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.</title>
<authorList>
<person name="Yoneyama M."/>
<person name="Kikuchi M."/>
<person name="Natsukawa T."/>
<person name="Shinobu N."/>
<person name="Imaizumi T."/>
<person name="Miyagishi M."/>
<person name="Taira K."/>
<person name="Akira S."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="15208624"/>
<dbReference type="DOI" id="10.1038/ni1087"/>
</citation>
<scope>INDUCTION</scope>
<scope>MUTAGENESIS OF LYS-270</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>BINDING TO DOUBLE-STRANDED RNA</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Cell" volume="122" first="669" last="682">
<title>Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.</title>
<authorList>
<person name="Seth R.B."/>
<person name="Sun L."/>
<person name="Ea C.-K."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="16125763"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.08.012"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAVS/IPS1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="4018" last="4028">
<title>SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.</title>
<authorList>
<person name="Huang J."/>
<person name="Liu T."/>
<person name="Xu L.-G."/>
<person name="Chen D."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="16281057"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600863"/>
</citation>
<scope>INTERACTION WITH IKBKE AND TBK1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="J. Virol." volume="79" first="2689" last="2699">
<title>Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.</title>
<authorList>
<person name="Sumpter R. Jr."/>
<person name="Loo Y.-M."/>
<person name="Foy E."/>
<person name="Li K."/>
<person name="Yoneyama M."/>
<person name="Fujita T."/>
<person name="Lemon S.M."/>
<person name="Gale M. Jr."/>
</authorList>
<dbReference type="PubMed" id="15708988"/>
<dbReference type="DOI" id="10.1128/JVI.79.5.2689-2699.2005"/>
</citation>
<scope>INDUCTION</scope>
<scope>MUTAGENESIS OF THR-55 AND LYS-270</scope>
<scope>BINDING TO DOUBLE-STRANDED RNA</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="727" last="740">
<title>VISA is an adapter protein required for virus-triggered IFN-beta Signaling.</title>
<authorList>
<person name="Xu L.-G."/>
<person name="Wang Y.-Y."/>
<person name="Han K.-J."/>
<person name="Li L.-Y."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="16153868"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.08.014"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAVS/IPS1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Nat. Immunol." volume="6" first="981" last="988">
<title>IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.</title>
<authorList>
<person name="Kawai T."/>
<person name="Takahashi K."/>
<person name="Sato S."/>
<person name="Coban C."/>
<person name="Kumar H."/>
<person name="Kato H."/>
<person name="Ishii K.J."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="16127453"/>
<dbReference type="DOI" id="10.1038/ni1243"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAVS/IPS1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="10200" last="10205">
<title>Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.</title>
<authorList>
<person name="Zhao C."/>
<person name="Denison C."/>
<person name="Huibregtse J.M."/>
<person name="Gygi S.P."/>
<person name="Krug R.M."/>
</authorList>
<dbReference type="PubMed" id="16009940"/>
<dbReference type="DOI" id="10.1073/pnas.0504754102"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>ISGYLATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Nature" volume="446" first="916" last="920">
<title>TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.</title>
<authorList>
<person name="Gack M.U."/>
<person name="Shin Y.C."/>
<person name="Joo C.H."/>
<person name="Urano T."/>
<person name="Liang C."/>
<person name="Sun L."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
<person name="Chen Z."/>
<person name="Inoue S."/>
<person name="Jung J.U."/>
</authorList>
<dbReference type="PubMed" id="17392790"/>
<dbReference type="DOI" id="10.1038/nature05732"/>
</citation>
<scope>INTERACTION WITH TRIM25</scope>
<scope>DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION AT LYS-172</scope>
<scope>MUTAGENESIS OF LYS-99; LYS-169; LYS-172; LYS-181 AND LYS-193</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="582" last="587">
<title>Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.</title>
<authorList>
<person name="Saito T."/>
<person name="Hirai R."/>
<person name="Loo Y.-M."/>
<person name="Owen D."/>
<person name="Johnson C.L."/>
<person name="Sinha S.C."/>
<person name="Akira S."/>
<person name="Fujita T."/>
<person name="Gale M. Jr."/>
</authorList>
<dbReference type="PubMed" id="17190814"/>
<dbReference type="DOI" id="10.1073/pnas.0606699104"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>RLR CTR DOMAIN</scope>
<scope>INTERACTION WITH DHX58</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="7500" last="7505">
<title>Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.</title>
<authorList>
<person name="Arimoto K."/>
<person name="Takahashi H."/>
<person name="Hishiki T."/>
<person name="Konishi H."/>
<person name="Fujita T."/>
<person name="Shimotohno K."/>
</authorList>
<dbReference type="PubMed" id="17460044"/>
<dbReference type="DOI" id="10.1073/pnas.0611551104"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="EMBO Rep." volume="9" first="930" last="936">
<title>The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.</title>
<authorList>
<person name="Friedman C.S."/>
<person name="O'Donnell M.A."/>
<person name="Legarda-Addison D."/>
<person name="Ng A."/>
<person name="Cardenas W.B."/>
<person name="Yount J.S."/>
<person name="Moran T.M."/>
<person name="Basler C.F."/>
<person name="Komuro A."/>
<person name="Horvath C.M."/>
<person name="Xavier R."/>
<person name="Ting A.T."/>
</authorList>
<dbReference type="PubMed" id="18636086"/>
<dbReference type="DOI" id="10.1038/embor.2008.136"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH CYLD</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Virol." volume="82" first="1474" last="1483">
<title>Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation.</title>
<authorList>
<person name="Kim M.J."/>
<person name="Hwang S.Y."/>
<person name="Imaizumi T."/>
<person name="Yoo J.Y."/>
</authorList>
<dbReference type="PubMed" id="18057259"/>
<dbReference type="DOI" id="10.1128/JVI.01650-07"/>
</citation>
<scope>ISGYLATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Nature" volume="455" first="674" last="678">
<title>STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling.</title>
<authorList>
<person name="Ishikawa H."/>
<person name="Barber G.N."/>
</authorList>
<dbReference type="PubMed" id="18724357"/>
<dbReference type="DOI" id="10.1038/nature07317"/>
</citation>
<scope>INTERACTION WITH TMEM173</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Cell" volume="138" first="576" last="591">
<title>RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.</title>
<authorList>
<person name="Chiu Y.-H."/>
<person name="Macmillan J.B."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="19631370"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.06.015"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Immunity" volume="31" first="25" last="34">
<title>Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.</title>
<authorList>
<person name="Schlee M."/>
<person name="Roth A."/>
<person name="Hornung V."/>
<person name="Hagmann C.A."/>
<person name="Wimmenauer V."/>
<person name="Barchet W."/>
<person name="Coch C."/>
<person name="Janke M."/>
<person name="Mihailovic A."/>
<person name="Wardle G."/>
<person name="Juranek S."/>
<person name="Kato H."/>
<person name="Kawai T."/>
<person name="Poeck H."/>
<person name="Fitzgerald K.A."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
<person name="Tuschl T."/>
<person name="Latz E."/>
<person name="Ludwig J."/>
<person name="Hartmann G."/>
</authorList>
<dbReference type="PubMed" id="19576794"/>
<dbReference type="DOI" id="10.1016/j.immuni.2009.05.008"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="807" last="817">
<title>Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection.</title>
<authorList>
<person name="Oshiumi H."/>
<person name="Matsumoto M."/>
<person name="Hatakeyama S."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="19017631"/>
<dbReference type="DOI" id="10.1074/jbc.M804259200"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH RNF135</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="6486" last="6494">
<title>Retinoic acid-induced gene-1 (RIG-I) associates with the actin cytoskeleton via caspase activation and recruitment domain-dependent interactions.</title>
<authorList>
<person name="Mukherjee A."/>
<person name="Morosky S.A."/>
<person name="Shen L."/>
<person name="Weber C.R."/>
<person name="Turner J.R."/>
<person name="Kim K.S."/>
<person name="Wang T."/>
<person name="Coyne C.B."/>
</authorList>
<dbReference type="PubMed" id="19122199"/>
<dbReference type="DOI" id="10.1074/jbc.M807547200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="9700" last="9712">
<title>Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2.</title>
<authorList>
<person name="Bamming D."/>
<person name="Horvath C.M."/>
</authorList>
<dbReference type="PubMed" id="19211564"/>
<dbReference type="DOI" id="10.1074/jbc.M807365200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="19122" last="19131">
<title>The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling.</title>
<authorList>
<person name="Johnsen I.B."/>
<person name="Nguyen T.T."/>
<person name="Bergstroem B."/>
<person name="Fitzgerald K.A."/>
<person name="Anthonsen M.W."/>
</authorList>
<dbReference type="PubMed" id="19419966"/>
<dbReference type="DOI" id="10.1074/jbc.M808233200"/>
</citation>
<scope>INTERACTION WITH SRC</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="3734" last="3742">
<title>Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I.</title>
<authorList>
<person name="Ling Z."/>
<person name="Tran K.C."/>
<person name="Teng M.N."/>
</authorList>
<dbReference type="PubMed" id="19193793"/>
<dbReference type="DOI" id="10.1128/JVI.02434-08"/>
</citation>
<scope>INTERACTION WITH HRSV PROTEIN NS2 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="Nat. Immunol." volume="10" first="1065" last="1072">
<title>RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate.</title>
<authorList>
<person name="Ablasser A."/>
<person name="Bauernfeind F."/>
<person name="Hartmann G."/>
<person name="Latz E."/>
<person name="Fitzgerald K.A."/>
<person name="Hornung V."/>
</authorList>
<dbReference type="PubMed" id="19609254"/>
<dbReference type="DOI" id="10.1038/ni.1779"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E5760" last="E5760">
<title>REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I.</title>
<authorList>
<person name="Gao D."/>
<person name="Yang Y.K."/>
<person name="Wang R.P."/>
<person name="Zhou X."/>
<person name="Diao F.C."/>
<person name="Li M.D."/>
<person name="Zhai Z.H."/>
<person name="Jiang Z.F."/>
<person name="Chen D.Y."/>
</authorList>
<dbReference type="PubMed" id="19484123"/>
<dbReference type="DOI" id="10.1371/journal.pone.0005760"/>
</citation>
<scope>UBIQUITINATION AT LYS-154; LYS-164 AND LYS-172</scope>
<scope>INTERACTION WITH RNF135</scope>
<scope>MUTAGENESIS OF LYS-154; LYS-164 AND LYS-172</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-858</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="Cell" volume="141" first="483" last="496">
<title>NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.</title>
<authorList>
<person name="Cui J."/>
<person name="Zhu L."/>
<person name="Xia X."/>
<person name="Wang H.Y."/>
<person name="Legras X."/>
<person name="Hong J."/>
<person name="Ji J."/>
<person name="Shen P."/>
<person name="Zheng S."/>
<person name="Chen Z.J."/>
<person name="Wang R.F."/>
</authorList>
<dbReference type="PubMed" id="20434986"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.03.040"/>
</citation>
<scope>INTERACTION WITH NLRC5</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Cell Res." volume="20" first="802" last="811">
<title>The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.</title>
<authorList>
<person name="Chen R."/>
<person name="Zhang L."/>
<person name="Zhong B."/>
<person name="Tan B."/>
<person name="Liu Y."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="20368735"/>
<dbReference type="DOI" id="10.1038/cr.2010.41"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP17L2</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Crit. Rev. Immunol." volume="30" first="489" last="513">
<title>Function and regulation of retinoic acid-inducible gene-I.</title>
<authorList>
<person name="Matsumiya T."/>
<person name="Stafforini D.M."/>
</authorList>
<dbReference type="PubMed" id="21175414"/>
<dbReference type="DOI" id="10.1615/CritRevImmunol.v30.i6.10"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="J. Virol." volume="84" first="1785" last="1791">
<title>Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction.</title>
<authorList>
<person name="Fan L."/>
<person name="Briese T."/>
<person name="Lipkin W.I."/>
</authorList>
<dbReference type="PubMed" id="20007272"/>
<dbReference type="DOI" id="10.1128/JVI.01362-09"/>
</citation>
<scope>INTERACTION WITH NEW WORLD ARENAVIRUSES PROTEIN Z (MICROBIAL INFECTION)</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="Immunity" volume="34" first="680" last="692">
<title>Immune signaling by RIG-I-like receptors.</title>
<authorList>
<person name="Loo Y.M."/>
<person name="Gale M. Jr."/>
</authorList>
<dbReference type="PubMed" id="21616437"/>
<dbReference type="DOI" id="10.1016/j.immuni.2011.05.003"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Immunol. Rev." volume="243" first="91" last="98">
<title>RIG-I-like receptors: cytoplasmic sensors for non-self RNA.</title>
<authorList>
<person name="Kato H."/>
<person name="Takahasi K."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="21884169"/>
<dbReference type="DOI" id="10.1111/j.1600-065X.2011.01052.x"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="J. Immunol." volume="187" first="1713" last="1721">
<title>Innate immune responses in human monocyte-derived dendritic cells are highly dependent on the size and the 5' phosphorylation of RNA molecules.</title>
<authorList>
<person name="Jiang M."/>
<person name="Osterlund P."/>
<person name="Sarin L.P."/>
<person name="Poranen M.M."/>
<person name="Bamford D.H."/>
<person name="Guo D."/>
<person name="Julkunen I."/>
</authorList>
<dbReference type="PubMed" id="21742966"/>
<dbReference type="DOI" id="10.4049/jimmunol.1100361"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="J. Immunol." volume="187" first="2559" last="2568">
<title>IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1.</title>
<authorList>
<person name="Liu X.Y."/>
<person name="Chen W."/>
<person name="Wei B."/>
<person name="Shan Y.F."/>
<person name="Wang C."/>
</authorList>
<dbReference type="PubMed" id="21813773"/>
<dbReference type="DOI" id="10.4049/jimmunol.1100963"/>
</citation>
<scope>INTERACTION WITH IFIT3</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="J. Interferon Cytokine Res." volume="31" first="27" last="31">
<title>Retinoic acid-inducible gene-I-like receptors.</title>
<authorList>
<person name="Onoguchi K."/>
<person name="Yoneyama M."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="20950133"/>
<dbReference type="DOI" id="10.1089/jir.2010.0057"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="J. Virol." volume="85" first="1036" last="1047">
<title>Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response.</title>
<authorList>
<person name="Sun Z."/>
<person name="Ren H."/>
<person name="Liu Y."/>
<person name="Teeling J.L."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="21068236"/>
<dbReference type="DOI" id="10.1128/JVI.01734-10"/>
</citation>
<scope>PHOSPHORYLATION AT THR-770; SER-854 AND SER-855</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="Mol. Cell. Biol." volume="31" first="3802" last="3819">
<title>DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling.</title>
<authorList>
<person name="Miyashita M."/>
<person name="Oshiumi H."/>
<person name="Matsumoto M."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="21791617"/>
<dbReference type="DOI" id="10.1128/MCB.01368-10"/>
</citation>
<scope>INTERACTION WITH DDX60</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="Nat. Immunol." volume="12" first="37" last="44">
<title>ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses.</title>
<authorList>
<person name="Hayakawa S."/>
<person name="Shiratori S."/>
<person name="Yamato H."/>
<person name="Kameyama T."/>
<person name="Kitatsuji C."/>
<person name="Kashigi F."/>
<person name="Goto S."/>
<person name="Kameoka S."/>
<person name="Fujikura D."/>
<person name="Yamada T."/>
<person name="Mizutani T."/>
<person name="Kazumata M."/>
<person name="Sato M."/>
<person name="Tanaka J."/>
<person name="Asaka M."/>
<person name="Ohba Y."/>
<person name="Miyazaki T."/>
<person name="Imamura M."/>
<person name="Takaoka A."/>
</authorList>
<dbReference type="PubMed" id="21102435"/>
<dbReference type="DOI" id="10.1038/ni.1963"/>
</citation>
<scope>INTERACTION WITH ZC3HAV1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="Virol. J." volume="8" first="526" last="526">
<title>Rotavirus nonstructural protein 1 antagonizes innate immune response by interacting with retinoic acid inducible gene I.</title>
<authorList>
<person name="Qin L."/>
<person name="Ren L."/>
<person name="Zhou Z."/>
<person name="Lei X."/>
<person name="Chen L."/>
<person name="Xue Q."/>
<person name="Liu X."/>
<person name="Wang J."/>
<person name="Hung T."/>
</authorList>
<dbReference type="PubMed" id="22152002"/>
<dbReference type="DOI" id="10.1186/1743-422X-8-526"/>
</citation>
<scope>INTERACTION WITH ROTAVIRUS PROTEIN NSP1 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2012" name="J. Virol." volume="86" first="3528" last="3540">
<title>Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5.</title>
<authorList>
<person name="Xing J."/>
<person name="Wang S."/>
<person name="Lin R."/>
<person name="Mossman K.L."/>
<person name="Zheng C."/>
</authorList>
<dbReference type="PubMed" id="22301138"/>
<dbReference type="DOI" id="10.1128/JVI.06713-11"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN US11 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2013" name="Immunol. Cell Biol." volume="91" first="321" last="330">
<title>Mitochondrially localised MUL1 is a novel modulator of antiviral signaling.</title>
<authorList>
<person name="Jenkins K."/>
<person name="Khoo J.J."/>
<person name="Sadler A."/>
<person name="Piganis R."/>
<person name="Wang D."/>
<person name="Borg N.A."/>
<person name="Hjerrild K."/>
<person name="Gould J."/>
<person name="Thomas B.J."/>
<person name="Nagley P."/>
<person name="Hertzog P.J."/>
<person name="Mansell A."/>
</authorList>
<dbReference type="PubMed" id="23399697"/>
<dbReference type="DOI" id="10.1038/icb.2013.7"/>
</citation>
<scope>SUMOYLATION BY MUL1</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2013" name="J. Virol." volume="87" first="10037" last="10046">
<title>Negative regulation of RIG-I-mediated innate antiviral signaling by SEC14L1.</title>
<authorList>
<person name="Li M.T."/>
<person name="Di W."/>
<person name="Xu H."/>
<person name="Yang Y.K."/>
<person name="Chen H.W."/>
<person name="Zhang F.X."/>
<person name="Zhai Z.H."/>
<person name="Chen D.Y."/>
</authorList>
<dbReference type="PubMed" id="23843640"/>
<dbReference type="DOI" id="10.1128/JVI.01073-13"/>
</citation>
<scope>INTERACTION WITH SEC14L1</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2014" name="J. Mol. Cell Biol." volume="6" first="154" last="163">
<title>TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination.</title>
<authorList>
<person name="Yan J."/>
<person name="Li Q."/>
<person name="Mao A.P."/>
<person name="Hu M.M."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="24755855"/>
<dbReference type="DOI" id="10.1093/jmcb/mju005"/>
</citation>
<scope>UBIQUITINATION AT LYS-154; LYS-164 AND LYS-172 BY TRIM4</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2015" name="EMBO J." volume="34" first="2903" last="2920">
<title>A non-canonical role of the p97 complex in RIG-I antiviral signaling.</title>
<authorList>
<person name="Hao Q."/>
<person name="Jiao S."/>
<person name="Shi Z."/>
<person name="Li C."/>
<person name="Meng X."/>
<person name="Zhang Z."/>
<person name="Wang Y."/>
<person name="Song X."/>
<person name="Wang W."/>
<person name="Zhang R."/>
<person name="Zhao Y."/>
<person name="Wong C.C."/>
<person name="Zhou Z."/>
</authorList>
<dbReference type="PubMed" id="26471729"/>
<dbReference type="DOI" id="10.15252/embj.201591888"/>
</citation>
<scope>UBIQUITINATION AT LYS-181 BY RNF125</scope>
<scope>INTERACTION WITH VCP</scope>
<scope>MUTAGENESIS OF LYS-181</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="96" first="266" last="274">
<title>Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome.</title>
<authorList>
<person name="Jang M.A."/>
<person name="Kim E.K."/>
<person name="Now H."/>
<person name="Nguyen N.T."/>
<person name="Kim W.J."/>
<person name="Yoo J.Y."/>
<person name="Lee J."/>
<person name="Jeong Y.M."/>
<person name="Kim C.H."/>
<person name="Kim O.H."/>
<person name="Sohn S."/>
<person name="Nam S.H."/>
<person name="Hong Y."/>
<person name="Lee Y.S."/>
<person name="Chang S.A."/>
<person name="Jang S.Y."/>
<person name="Kim J.W."/>
<person name="Lee M.S."/>
<person name="Lim S.Y."/>
<person name="Sung K.S."/>
<person name="Park K.T."/>
<person name="Kim B.J."/>
<person name="Lee J.H."/>
<person name="Kim D.K."/>
<person name="Kee C."/>
<person name="Ki C.S."/>
</authorList>
<dbReference type="PubMed" id="25620203"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2014.11.019"/>
</citation>
<scope>INVOLVEMENT IN SGMRT2</scope>
<scope>VARIANTS SGMRT2 PHE-268 AND ALA-373</scope>
<scope>CHARACTERIZATION OF VARIANTS SGMRT2 PHE-268 AND ALA-373</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="169" last="179">
<title>The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I.</title>
<authorList>
<person name="Cui S."/>
<person name="Eisenaecher K."/>
<person name="Kirchhofer A."/>
<person name="Brzozka K."/>
<person name="Lammens A."/>
<person name="Lammens K."/>
<person name="Fujita T."/>
<person name="Conzelmann K.-K."/>
<person name="Krug A."/>
<person name="Hopfner K.-P."/>
</authorList>
<dbReference type="PubMed" id="18243112"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.10.032"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 802-925 IN COMPLEX WITH ZINC IONS</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="428" last="440">
<title>Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses.</title>
<authorList>
<person name="Takahasi K."/>
<person name="Yoneyama M."/>
<person name="Nishihori T."/>
<person name="Hirai R."/>
<person name="Kumeta H."/>
<person name="Narita R."/>
<person name="Gale M. Jr."/>
<person name="Inagaki F."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="18242112"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.11.028"/>
</citation>
<scope>STRUCTURE BY NMR OF 792-925</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2014" name="Mol. Cell" volume="55" first="511" last="523">
<title>Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I.</title>
<authorList>
<person name="Wu B."/>
<person name="Peisley A."/>
<person name="Tetrault D."/>
<person name="Li Z."/>
<person name="Egelman E.H."/>
<person name="Magor K.E."/>
<person name="Walz T."/>
<person name="Penczek P.A."/>
<person name="Hur S."/>
</authorList>
<dbReference type="PubMed" id="25018021"/>
<dbReference type="DOI" id="10.1016/j.molcel.2014.06.010"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 1-201 IN COMPLEX WITH MAVS</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="16 18 20 21 22 24 30 33 35 38 39 40 46">Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and proinflammatory cytokines. Its ligands include: 5'-triphosphorylated ssRNA and dsRNA and short dsRNA (&lt;1 kb in length). In addition to the 5'-triphosphate moiety, blunt-end base pairing at the 5'-end of the RNA is very essential. Overhangs at the non-triphosphorylated end of the dsRNA RNA have no major impact on its activity. A 3'overhang at the 5'triphosphate end decreases and any 5'overhang at the 5' triphosphate end abolishes its activity. Upon ligand binding it associates with mitochondria antiviral signaling protein (MAVS/IPS1) which activates the IKK-related kinases: TBK1 and IKBKE which phosphorylate interferon regulatory factors: IRF3 and IRF7 which in turn activate transcription of antiviral immunological genes, including interferons (IFNs); IFN-alpha and IFN-beta. Detects both positive and negative strand RNA viruses including members of the families Paramyxoviridae: Human respiratory syncytial virus and measles virus (MeV), Rhabdoviridae: vesicular stomatitis virus (VSV), Orthomyxoviridae: influenza A and B virus, Flaviviridae: Japanese encephalitis virus (JEV), hepatitis C virus (HCV), dengue virus (DENV) and west Nile virus (WNV). It also detects rotavirus and reovirus. Also involved in antiviral signaling in response to viruses containing a dsDNA genome such as Epstein-Barr virus (EBV). Detects dsRNA produced from non-self dsDNA by RNA polymerase III, such as Epstein-Barr virus-encoded RNAs (EBERs). May play important roles in granulocyte production and differentiation, bacterial phagocytosis and in the regulation of cell migration.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + H(2)O = ADP + phosphate.</text>
</comment>
<comment type="subunit">
<text evidence="20 21 22 23 24 25 29 30 31 32 36 37 43 45 47 48 52 54 56">Monomer; maintained as a monomer in an autoinhibited state. Upon viral dsRNA binding and conformation shift, homomultimerizes and interacts (via tandem CARD domain) with MAVS/IPS1 promoting its filamentation. Interacts with DHX58/LGP2, IKBKE, TBK1 and TMEM173/STING. Interacts (via CARD domain) with TRIM25 (via SPRY domain). Interacts with RNF135. Interacts with CYLD. Interacts with NLRC5; blocks the interaction of MAVS/IPS1 to DDX58. Interacts with SRC. Interacts with DDX60. Interacts with isoform 2 of ZC3HAV1 (via zinc-fingers) in an RNA-dependent manner. Interacts (via tandem CARD domain) with SEC14L1; the interaction is direct and impairs the interaction of DDX58 with MAVS/IPS1. Interacts with VCP/p97; interaction is direct and leads to recruit RNF125 and subsequent ubiquitination and degradation (PubMed:26471729).</text>
</comment>
<comment type="subunit">
<text evidence="41">(Microbial infection) Interacts with protein Z of Guanarito virus, Machupo virus, Junin arenavirus and Sabia virus. This interaction disrupts its interaction with MAVS/IPS1, impeding downstream IRF3 and NF-kappa-B activation and resulting in decreased IFN-beta induction (PubMed:20007272).</text>
</comment>
<comment type="subunit">
<text evidence="34">(Microbial infection) Interacts (via CARD domain) with Human respiratory syncytial virus A non-structural protein 2 (NS2) and this interaction disrupts its interaction with MAVS/IPS1, impeding downstream IRF3 activation (PubMed:19193793).</text>
</comment>
<comment type="subunit">
<text evidence="49">(Microbial infection) Interacts with Rotavirus A non-structural protein 1 (NSP1) and this interaction induces down-regulation of DDX58/RIG-I (PubMed:22152002).</text>
</comment>
<comment type="subunit">
<text evidence="50">(Microbial infection) Interacts with herpes simplex virus 1 protein US11; this interaction prevents the interaction of MAVS/IPS1 to DDX58 (PubMed:22301138).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-995350"/>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-9687469">
<id>F1BA49</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-3648048">
<id>P04543</id>
<label>1B</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-1374296">
<id>Q920D5</id>
<label>Casp12</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-2117940">
<id>Q9NQC7</id>
<label>CYLD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-353779">
<id>O00571</id>
<label>DDX3X</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
<label>MAVS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-6693910">
<id>P21699</id>
<label>NSS</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-713955">
<id>O75569</id>
<label>PRKRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-2341129">
<id>Q14258</id>
<label>TRIM25</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-6150681">
<id>P04487</id>
<label>US11</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-2513471">
<id>Q96S55</id>
<label>WRNIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-3647473">
<id>Q6IUF9</id>
<label>Z</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-3647294">
<id>Q6IVU5</id>
<label>Z</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-3647496">
<id>Q6UY62</id>
<label>Z</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-3647448">
<id>Q6UY71</id>
<label>Z</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-922540">
<id>Q7Z2W4</id>
<label>ZC3HAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-995350"/>
<interactant intactId="EBI-922559">
<id>Q7Z2W4-2</id>
<label>ZC3HAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell projection</location>
<location>Ruffle membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell junction</location>
<location>Tight junction</location>
</subcellularLocation>
<text>Colocalized with TRIM25 at cytoplasmic perinuclear bodies. Associated with the actin cytoskeleton at membrane ruffles.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O95786-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O95786-2</id>
<name>2</name>
<sequence type="described" ref="VSP_016054"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="17">Present in vascular smooth cells (at protein level).</text>
</comment>
<comment type="induction">
<text evidence="14 15 16 17 18">By bacterial lipopolysaccharides (LPS) in endothelial cells. By interferon (IFN).</text>
</comment>
<comment type="domain">
<text>The RLR CTR domain controls homomultimerization and interaction with MAVS/IPS1. In the absence of viral infection, the protein is maintained as a monomer in an autoinhibited state with the CARD domains masked through intramolecular interactions mediated by the RLR CTR domain. Upon binding to viral RNA in the presence of ATP, the RLR CTR domain induces a conformational change exposing the CARD domain and promotes dimerization and CARD interactions with the adapter protein MAVS/IPS1 leading to the induction of downstream signaling.</text>
</comment>
<comment type="domain">
<text>The helicase domain is responsible for dsRNA recognition.</text>
</comment>
<comment type="domain">
<text>The 2 CARD domains are responsible for interaction with and signaling through MAVS/IPS1 and for association with the actin cytoskeleton.</text>
</comment>
<comment type="domain">
<text evidence="25">The second CARD domain is the primary site for 'Lys-63'-linked ubiquitination.</text>
</comment>
<comment type="PTM">
<text evidence="44">Phosphorylated in resting cells and dephosphorylated in RNA virus-infected cells. Phosphorylation at Thr-770, Ser-854 and Ser-855 results in inhibition of its activity while dephosphorylation at these sites results in its activation.</text>
</comment>
<comment type="PTM">
<text evidence="19 28 42">ISGylated. Conjugated to ubiquitin-like protein ISG15 upon IFN-beta stimulation. ISGylation negatively regulates its function in antiviral signaling response.</text>
</comment>
<comment type="PTM">
<text evidence="42 51">Sumoylated, probably by MUL1; inhibiting its polyubiquitination.</text>
</comment>
<comment type="PTM">
<text evidence="25 26 30 32 37 42 53 56">Ubiquitinated. Undergoes 'Lys-48'- and 'Lys-63'-linked ubiquitination. Lys-172 is the critical site for TRIM25-mediated ubiquitination, for MAVS/IPS1 binding and to induce anti-viral signal transduction (PubMed:17392790). Lys-154, Lys-164 and Lys-172 are critical sites for RNF135-mediated and TRIM4-mediated ubiquitination (PubMed:19017631, PubMed:19484123, PubMed:24755855). Deubiquitinated by CYLD, a protease that selectively cleaves 'Lys-63'-linked ubiquitin chains (PubMed:18636086). Also probably deubiquitinated by USP17L2/USP17 that cleaves 'Lys-48'-and 'Lys-63'-linked ubiquitin chains and positively regulates the receptor (PubMed:20368735). Ubiquitinated at Lys-181 by RNF125, leading to its degradation: ubiquitination takes place upon viral infection and is enhanced 'Lys-63'-linked ubiquitination of the CARD domains, which promote interaction with VCP/p97 and subsequent recruitment of RNF125 (PubMed:17460044, PubMed:26471729).</text>
</comment>
<comment type="disease" evidence="55">
<disease id="DI-04387">
<name>Singleton-Merten syndrome 2</name>
<acronym>SGMRT2</acronym>
<description>A form of Singleton-Merten syndrome, an autosomal dominant disorder characterized by marked aortic calcification, dental anomalies, osteopenia, acro-osteolysis, and to a lesser extend glaucoma, psoriasis, muscle weakness, and joint laxity. Additional clinical manifestations include particular facial characteristics and abnormal joint and muscle ligaments. SGMRT2 is an atypical form characterized by variable expression of glaucoma, aortic calcification, and skeletal abnormalities, without dental anomalies.</description>
<dbReference type="MIM" id="616298"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="59">Belongs to the helicase family. RLR subfamily.</text>
</comment>
<dbReference type="EC" id="3.6.4.13"/>
<dbReference type="EMBL" id="AF038963">
<property type="protein sequence ID" value="AAD19826.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353671">
<property type="protein sequence ID" value="CAH71251.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL161783">
<property type="protein sequence ID" value="CAH71251.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL161783">
<property type="protein sequence ID" value="CAH72600.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353671">
<property type="protein sequence ID" value="CAH72600.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58548.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC132786">
<property type="protein sequence ID" value="AAI32787.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC136610">
<property type="protein sequence ID" value="AAI36611.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX647917">
<property type="protein sequence ID" value="CAI46068.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL137608">
<property type="protein sequence ID" value="CAB70840.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6526.1">
<molecule id="O95786-1"/>
</dbReference>
<dbReference type="PIR" id="T46312">
<property type="entry name" value="T46312"/>
</dbReference>
<dbReference type="RefSeq" id="NP_055129.2">
<molecule id="O95786-1"/>
<property type="nucleotide sequence ID" value="NM_014314.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.190622"/>
<dbReference type="PDB" id="2LWD">
<property type="method" value="NMR"/>
<property type="chains" value="A=95-190"/>
</dbReference>
<dbReference type="PDB" id="2LWE">
<property type="method" value="NMR"/>
<property type="chains" value="A=95-190"/>
</dbReference>
<dbReference type="PDB" id="2QFB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J=802-925"/>
</dbReference>
<dbReference type="PDB" id="2QFD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J=802-925"/>
</dbReference>
<dbReference type="PDB" id="2RMJ">
<property type="method" value="NMR"/>
<property type="chains" value="A=792-925"/>
</dbReference>
<dbReference type="PDB" id="2YKG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=230-925"/>
</dbReference>
<dbReference type="PDB" id="3LRN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=803-923"/>
</dbReference>
<dbReference type="PDB" id="3LRR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=803-923"/>
</dbReference>
<dbReference type="PDB" id="3NCU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B=792-925"/>
</dbReference>
<dbReference type="PDB" id="3OG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=802-925"/>
</dbReference>
<dbReference type="PDB" id="3ZD6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=230-925"/>
</dbReference>
<dbReference type="PDB" id="3ZD7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=230-925"/>
</dbReference>
<dbReference type="PDB" id="4AY2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=239-925"/>
</dbReference>
<dbReference type="PDB" id="4BPB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A=230-925"/>
</dbReference>
<dbReference type="PDB" id="4NQK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="A/B/C/D=1-200"/>
</dbReference>
<dbReference type="PDB" id="4ON9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="A/B=230-793"/>
</dbReference>
<dbReference type="PDB" id="4P4H">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B/C/D/E/F/G/H=1-201"/>
</dbReference>
<dbReference type="PDB" id="5E3H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=232-925"/>
</dbReference>
<dbReference type="PDB" id="5F98">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.28"/>
<property type="chains" value="A/C/E/G/I/K=232-925"/>
</dbReference>
<dbReference type="PDB" id="5F9F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C/E/G/I/K=232-925"/>
</dbReference>
<dbReference type="PDB" id="5F9H">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/C/E/G/I/K=232-925"/>
</dbReference>
<dbReference type="PDBsum" id="2LWD"/>
<dbReference type="PDBsum" id="2LWE"/>
<dbReference type="PDBsum" id="2QFB"/>
<dbReference type="PDBsum" id="2QFD"/>
<dbReference type="PDBsum" id="2RMJ"/>
<dbReference type="PDBsum" id="2YKG"/>
<dbReference type="PDBsum" id="3LRN"/>
<dbReference type="PDBsum" id="3LRR"/>
<dbReference type="PDBsum" id="3NCU"/>
<dbReference type="PDBsum" id="3OG8"/>
<dbReference type="PDBsum" id="3ZD6"/>
<dbReference type="PDBsum" id="3ZD7"/>
<dbReference type="PDBsum" id="4AY2"/>
<dbReference type="PDBsum" id="4BPB"/>
<dbReference type="PDBsum" id="4NQK"/>
<dbReference type="PDBsum" id="4ON9"/>
<dbReference type="PDBsum" id="4P4H"/>
<dbReference type="PDBsum" id="5E3H"/>
<dbReference type="PDBsum" id="5F98"/>
<dbReference type="PDBsum" id="5F9F"/>
<dbReference type="PDBsum" id="5F9H"/>
<dbReference type="ProteinModelPortal" id="O95786"/>
<dbReference type="SMR" id="O95786"/>
<dbReference type="BioGrid" id="117121">
<property type="interactions" value="41"/>
</dbReference>
<dbReference type="DIP" id="DIP-35444N"/>
<dbReference type="IntAct" id="O95786">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="MINT" id="MINT-2799116"/>
<dbReference type="STRING" id="9606.ENSP00000369213"/>
<dbReference type="iPTMnet" id="O95786"/>
<dbReference type="PhosphoSitePlus" id="O95786"/>
<dbReference type="BioMuta" id="DDX58"/>
<dbReference type="EPD" id="O95786"/>
<dbReference type="MaxQB" id="O95786"/>
<dbReference type="PaxDb" id="O95786"/>
<dbReference type="PeptideAtlas" id="O95786"/>
<dbReference type="PRIDE" id="O95786"/>
<dbReference type="Ensembl" id="ENST00000379883">
<molecule id="O95786-1"/>
<property type="protein sequence ID" value="ENSP00000369213"/>
<property type="gene ID" value="ENSG00000107201"/>
</dbReference>
<dbReference type="GeneID" id="23586"/>
<dbReference type="KEGG" id="hsa:23586"/>
<dbReference type="UCSC" id="uc003zra.4">
<molecule id="O95786-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="23586"/>
<dbReference type="DisGeNET" id="23586"/>
<dbReference type="GeneCards" id="DDX58"/>
<dbReference type="HGNC" id="HGNC:19102">
<property type="gene designation" value="DDX58"/>
</dbReference>
<dbReference type="HPA" id="CAB012643"/>
<dbReference type="HPA" id="HPA047193"/>
<dbReference type="MalaCards" id="DDX58"/>
<dbReference type="MIM" id="609631">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616298">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O95786"/>
<dbReference type="OpenTargets" id="ENSG00000107201"/>
<dbReference type="PharmGKB" id="PA134994272"/>
<dbReference type="eggNOG" id="KOG0354">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG1111">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00510000046789"/>
<dbReference type="HOGENOM" id="HOG000230911"/>
<dbReference type="HOVERGEN" id="HBG052325"/>
<dbReference type="InParanoid" id="O95786"/>
<dbReference type="KO" id="K12646"/>
<dbReference type="OMA" id="RTTDRFK"/>
<dbReference type="OrthoDB" id="EOG091G01PQ"/>
<dbReference type="PhylomeDB" id="O95786"/>
<dbReference type="TreeFam" id="TF330258"/>
<dbReference type="Reactome" id="R-HSA-1169408">
<property type="pathway name" value="ISG15 antiviral mechanism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168928">
<property type="pathway name" value="RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-918233">
<property type="pathway name" value="TRAF3-dependent IRF activation pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933541">
<property type="pathway name" value="TRAF6 mediated IRF7 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933542">
<property type="pathway name" value="TRAF6 mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933543">
<property type="pathway name" value="NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936440">
<property type="pathway name" value="Negative regulators of RIG-I/MDA5 signaling"/>
</dbReference>
<dbReference type="SIGNOR" id="O95786"/>
<dbReference type="ChiTaRS" id="DDX58">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O95786"/>
<dbReference type="GeneWiki" id="RIG-I"/>
<dbReference type="GenomeRNAi" id="23586"/>
<dbReference type="PRO" id="PR:O95786"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000107201"/>
<dbReference type="CleanEx" id="HS_DDX58"/>
<dbReference type="ExpressionAtlas" id="O95786">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O95786">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0015629">
<property type="term" value="C:actin cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005923">
<property type="term" value="C:bicellular tight junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0032587">
<property type="term" value="C:ruffle membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003725">
<property type="term" value="F:double-stranded RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004386">
<property type="term" value="F:helicase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0003727">
<property type="term" value="F:single-stranded RNA binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0039528">
<property type="term" value="P:cytoplasmic pattern recognition receptor signaling pathway in response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009597">
<property type="term" value="P:detection of virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032480">
<property type="term" value="P:negative regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002230">
<property type="term" value="P:positive regulation of defense response to virus by host"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0032725">
<property type="term" value="P:positive regulation of granulocyte macrophage colony-stimulating factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of sequence-specific DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042993">
<property type="term" value="P:positive regulation of transcription factor import into nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030334">
<property type="term" value="P:regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034344">
<property type="term" value="P:regulation of type III interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043330">
<property type="term" value="P:response to exogenous dsRNA"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0039529">
<property type="term" value="P:RIG-I signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR031964">
<property type="entry name" value="CARD_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011545">
<property type="entry name" value="DEAD/DEAH_box_helicase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR014001">
<property type="entry name" value="Helicase_ATP-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001650">
<property type="entry name" value="Helicase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR021673">
<property type="entry name" value="RLR_CTR"/>
</dbReference>
<dbReference type="Pfam" id="PF16739">
<property type="entry name" value="CARD_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00270">
<property type="entry name" value="DEAD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00271">
<property type="entry name" value="Helicase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF11648">
<property type="entry name" value="RIG-I_C-RD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00487">
<property type="entry name" value="DEXDc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00490">
<property type="entry name" value="HELICc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS51192">
<property type="entry name" value="HELICASE_ATP_BIND_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51194">
<property type="entry name" value="HELICASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51789">
<property type="entry name" value="RLR_CTR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0347">Helicase</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0796">Tight junction</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Probable ATP-dependent RNA helicase DDX58" id="PRO_0000144093">
<location>
<begin position="1"/>
<end position="925"/>
</location>
</feature>
<feature type="domain" description="CARD 1">
<location>
<begin position="1"/>
<end position="87"/>
</location>
</feature>
<feature type="domain" description="CARD 2">
<location>
<begin position="92"/>
<end position="172"/>
</location>
</feature>
<feature type="domain" description="Helicase ATP-binding" evidence="11">
<location>
<begin position="251"/>
<end position="430"/>
</location>
</feature>
<feature type="domain" description="Helicase C-terminal" evidence="12">
<location>
<begin position="610"/>
<end position="776"/>
</location>
</feature>
<feature type="domain" description="RLR CTR" evidence="13">
<location>
<begin position="794"/>
<end position="925"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="59">
<location>
<begin position="264"/>
<end position="271"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ZC3HAV1" evidence="45">
<location>
<begin position="218"/>
<end position="925"/>
</location>
</feature>
<feature type="short sequence motif" description="DECH box">
<location>
<begin position="372"/>
<end position="375"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="13">
<location>
<position position="810"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="13">
<location>
<position position="813"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="13">
<location>
<position position="864"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="13">
<location>
<position position="869"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CK2" evidence="44">
<location>
<position position="770"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="44">
<location>
<position position="854"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="44">
<location>
<position position="855"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="10">
<location>
<position position="858"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="37">
<location>
<position position="154"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="37">
<location>
<position position="164"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="37">
<location>
<position position="172"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="56">
<location>
<position position="181"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_016054" evidence="58">
<location>
<begin position="36"/>
<end position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10813831." id="VAR_023747" evidence="27">
<original>R</original>
<variation>C</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence variant" description="In SGMRT2; results in constitutive activation and enhanced interferon-mediated signaling; dbSNP:rs786204848." id="VAR_073667" evidence="55">
<original>C</original>
<variation>F</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In SGMRT2; results in constitutive activation and enhanced interferon-mediated signaling; dbSNP:rs786204847." id="VAR_073668" evidence="55">
<original>E</original>
<variation>A</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17217280." id="VAR_023748" evidence="14 57">
<original>D</original>
<variation>E</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="mutagenesis site" description="No IRF3 signaling activity; no effect on dsRNA binding." evidence="18">
<original>T</original>
<variation>I</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little or no effect on ubiquitination of the 2 CARD domain. Abolishes ubiquitination by RNF125." evidence="25 56">
<original>K</original>
<variation>R</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduction of ubiquitination. Reduction of INFB induction." evidence="37">
<original>K</original>
<variation>R</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduction of ubiquitination. Reduction of INFB induction." evidence="37">
<original>K</original>
<variation>R</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little or no effect on ubiquitination of the 2 CARD domains." evidence="25">
<original>K</original>
<variation>R</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of ubiquitination; No interaction with MAVS/IPS1; No induction of IFN-beta." evidence="25 37">
<original>K</original>
<variation>R</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little or no effect on ubiquitination of the 2 CARD domains." evidence="25">
<original>K</original>
<variation>R</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little or no effect on ubiquitination of the 2 CARD domains.">
<original>K</original>
<variation>R</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="mutagenesis site" description="Little or no effect on ubiquitination of the 2 CARD domains." evidence="25">
<original>K</original>
<variation>R</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="No IRF3 signaling activity." evidence="16 18">
<original>K</original>
<variation>A</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="2"/>
<end position="11"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="13"/>
<end position="19"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="22"/>
<end position="25"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="26"/>
<end position="32"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="35"/>
<end position="48"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="50"/>
<end position="63"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="69"/>
<end position="80"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="83"/>
<end position="85"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="86"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="95"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="101"/>
<end position="117"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="120"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="128"/>
<end position="130"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="133"/>
<end position="146"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="148"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="167"/>
<end position="177"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="183"/>
<end position="185"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="245"/>
<end position="255"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="260"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="270"/>
<end position="284"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="293"/>
<end position="296"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="300"/>
<end position="313"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="314"/>
<end position="318"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="321"/>
<end position="324"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="326"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="330"/>
<end position="332"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="334"/>
<end position="339"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="342"/>
<end position="346"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="348"/>
<end position="356"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="358"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="363"/>
<end position="365"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="367"/>
<end position="372"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="374"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="382"/>
<end position="395"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="396"/>
<end position="398"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="404"/>
<end position="410"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="420"/>
<end position="433"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="438"/>
<end position="440"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="443"/>
<end position="445"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="446"/>
<end position="452"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="457"/>
<end position="462"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="470"/>
<end position="489"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="493"/>
<end position="495"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="496"/>
<end position="498"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="504"/>
<end position="506"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="507"/>
<end position="518"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="526"/>
<end position="528"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="531"/>
<end position="557"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="560"/>
<end position="575"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="581"/>
<end position="591"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="594"/>
<end position="602"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="604"/>
<end position="606"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="609"/>
<end position="622"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="630"/>
<end position="633"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="637"/>
<end position="649"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="651"/>
<end position="653"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="658"/>
<end position="660"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="675"/>
<end position="683"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="686"/>
<end position="690"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="694"/>
<end position="700"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="701"/>
<end position="703"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="706"/>
<end position="708"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="710"/>
<end position="716"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="721"/>
<end position="726"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="727"/>
<end position="731"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="737"/>
<end position="743"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="745"/>
<end position="768"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="773"/>
<end position="793"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="801"/>
<end position="804"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="806"/>
<end position="810"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="811"/>
<end position="813"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="816"/>
<end position="819"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="820"/>
<end position="822"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="823"/>
<end position="826"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="827"/>
<end position="829"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="830"/>
<end position="833"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="836"/>
<end position="839"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="842"/>
<end position="846"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="856"/>
<end position="864"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="867"/>
<end position="869"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="872"/>
<end position="879"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="882"/>
<end position="887"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="889"/>
<end position="891"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="892"/>
<end position="896"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="897"/>
<end position="899"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="902"/>
<end position="904"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="908"/>
<end position="910"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="920"/>
<end position="922"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2RMJ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2YKG"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LRR"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ZD7"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4BPB"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ON9"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4P4H"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5F98"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5F9F"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00541"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00542"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01125"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11890704"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15181474"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15208624"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15219805"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15708988"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16009940"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16125763"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16127453"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16153868"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16281057"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17190814"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17392790"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17460044"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18057259"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18243112"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18636086"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18724357"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19017631"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19122199"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19193793"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19211564"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19419966"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19484123"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19576794"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19609254"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19631370"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20007272"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20368735"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20434986"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21068236"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21102435"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21742966"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21791617"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21813773"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22152002"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22301138"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23399697"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23843640"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24755855"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25018021"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25620203"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26471729"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source ref="1"/>
</evidence>
<evidence key="58" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000305"/>
<sequence length="925" mass="106600" checksum="BF0D501C395BAE25" modified="2005-11-08" version="2">
MTTEQRRSLQAFQDYIRKTLDPTYILSYMAPWFREEEVQYIQAEKNNKGPMEAATLFLKF
LLELQEEGWFRGFLDALDHAGYSGLYEAIESWDFKKIEKLEEYRLLLKRLQPEFKTRIIP
TDIISDLSECLINQECEEILQICSTKGMMAGAEKLVECLLRSDKENWPKTLKLALEKERN
KFSELWIVEKGIKDVETEDLEDKMETSDIQIFYQEDPECQNLSENSCPPSEVSDTNLYSP
FKPRNYQLELALPAMKGKNTIICAPTGCGKTFVSLLICEHHLKKFPQGQKGKVVFFANQI
PVYEQQKSVFSKYFERHGYRVTGISGATAENVPVEQIVENNDIIILTPQILVNNLKKGTI
PSLSIFTLMIFDECHNTSKQHPYNMIMFNYLDQKLGGSSGPLPQVIGLTASVGVGDAKNT
DEALDYICKLCASLDASVIATVKHNLEELEQVVYKPQKFFRKVESRISDKFKYIIAQLMR
DTESLAKRICKDLENLSQIQNREFGTQKYEQWIVTVQKACMVFQMPDKDEESRICKALFL
YTSHLRKYNDALIISEHARMKDALDYLKDFFSNVRAAGFDEIEQDLTQRFEEKLQELESV
SRDPSNENPKLEDLCFILQEEYHLNPETITILFVKTRALVDALKNWIEGNPKLSFLKPGI
LTGRGKTNQNTGMTLPAQKCILDAFKASGDHNILIATSVADEGIDIAQCNLVILYEYVGN
VIKMIQTRGRGRARGSKCFLLTSNAGVIEKEQINMYKEKMMNDSILRLQTWDEAVFREKI
LHIQTHEKFIRDSQEKPKPVPDKENKKLLCRKCKALACYTADVRVIEECHYTVLGDAFKE
CFVSRPHPKPKQFSSFEKRAKIFCARQNCSHDWGIHVKYKTFEIPVIKIESFVVEDIATG
VQTLYSKWKDFHFEKIPFDPAEMSK
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>